Articles tagged with Endometriosis
A University of Queensland study found that undiagnosed endometriosis can lead to higher cycle numbers and reduced birth rates among women undergoing fertility treatment. The research highlights the importance of early diagnosis and treatment adjustments to improve fertility outcomes.
A genetic analysis of humans and rhesus macaques identified the NPSR1 gene as a risk factor for endometriosis. The study found that rare variants in this gene are associated with stage III/IV disease, leading to potential nonhormonal treatment targets for improved therapy.
A recent focus group study investigated the factors affecting endometriosis diagnosis, revealing significant delays in diagnosis. Women with endometriosis reported an average time of 8.5 years from symptom onset to diagnosis, highlighting a lack of knowledge and understanding among patients, relatives, and doctors.
Research published in Acta Obstetricia et Gynecologica Scandinavica finds endometriosis affects work ability and sick leave in mid-life women. A life course approach reveals poor work outcomes without association with unemployment or early retirement.
A new study suggests that night shift work is associated with menstrual irregularity and an increased risk of developing endometriosis. Researchers found altered expressions of core clock genes in ectopic and eutopic endometrial tissues, indicating a disturbance of biological timing.
A study published in the journal Pain identifies specialised ion channels involved in transmitting pain signals from the female reproductive tract. The research provides novel findings that could lead to improved treatment options for women experiencing chronic pelvic pain associated with endometriosis and vulvodynia.
A new study published in the European Society of Human Reproduction and Embryology found that tanning bed use and sunburns may increase a woman's chances of developing endometriosis. The research analyzed data from over 116,000 women and found a higher risk among those who used tanning beds frequently or got sunburnt during teenage years.
Researchers at Michigan State University have identified a potential genetic target for treating an especially painful and invasive form of endometriosis. They discovered that targeting super-enhancers, altered by a mutation in the ARID1A gene, could lead to effective treatment using epigenetic therapy.
Researchers investigate transvaginal ultrasound as an alternative to invasive laparoscopic surgery for diagnosing deep infiltrating endometriosis. The study finds TVUS to be highly accurate in detecting the condition, reducing diagnostic delays and improving patient outcomes.
Research funded by the NIH has linked endometriosis to DNA changes, particularly in methylation patterns that can alter gene activity. The findings may inform new ways to diagnose and treat this condition affecting up to 10% of U.S. women.
Researchers at Oregon State University have developed a photo-responsive nanoparticle-based treatment to alleviate the symptoms of endometriosis. The nanoparticles can detect and remove lesions associated with the disorder, offering a promising new approach to treating the condition.
A 66-year-long study found that tall and lean girls are at a higher risk of developing endometriosis. However, results also showed that girls with a higher childhood BMI have a lower risk of the disease, suggesting biological mechanisms may be involved.
Researchers will investigate the association between endocrine disruptors and endometriosis severity. The study aims to answer two key questions: whether levels of these chemicals inside the uterus are linked to endometriosis and if they affect the severity of the disorder.
Researchers found that cannabinoids can relieve pain caused by endometriosis and improve cognitive function in mice with the condition. THC treatment also reduced endometrial growths, suggesting a potential therapeutic effect.
A study of 16 participants found that women with endometriosis secrete higher levels of lactate than those without the condition. Exposure to dichloroacetate reduced lactate secretion and cell proliferation in human cell-culture models.
Researchers found that dichloroacetate treatment lowered lactate production and stopped abnormal cell growth in women with endometriosis. The study suggests a new non-hormonal treatment option for the condition, which affects millions of women worldwide.
A new study found that over three-quarters of Australian women with endometriosis use self-management strategies like breathing techniques, yoga, and dietary changes, with cannabis being the most effective treatment. Women reported significant reductions in pain, nausea, and depression symptoms, as well as a decrease in medication usage.
A new study estimates that endometriosis may be costing the Australian economy as much as $9.7 billion dollars per year due to productivity loss and other expenses. The condition affects around one in nine women born between 1973-78, causing severe pelvic pain and fatigue.
Biomedical researchers have created three-dimensional cell structures from diseased tissue of patients to study endometrial diseases like endometriosis and cancer. This new biobank can help unravel disorders and test drugs for effective treatments.
Researchers uncover the role of macrophages in causing pelvic pain in endometriosis, potentially leading to new non-hormonal treatments. The discovery was published in The FASEB Journal and found increased production of IGF-1 by macrophages, which encourages nerve growth and activation.
A small study suggests that treating pelvic floor muscle spasm with botulinum toxin may relieve pain and improve quality of life in women with endometriosis. The treatment showed long-lasting benefits, with many patients reporting pain relief lasting at least six months.
Researchers analyzed 80 endometrium samples to improve diagnosis accuracy. They found that the day of menstrual cycle reported by women often does not match the actual phase. The study aims to establish causes and treatments for endometriosis, a disease affecting 10-15% of reproductive-aged women.
Researchers discover that metronidazole reduces lesions caused by endometriosis in mice, suggesting a potential treatment for the painful condition. The study also reveals that gut microbiota may play a role in driving or preventing endometriosis progression.
Researchers at Northwestern Medicine have successfully reprogrammed induced pluripotent stem cells into healthy uterine cells for potential treatment of endometriosis. The study marks a significant step towards treating the painful and persistent gynecological disease, which affects approximately 10% of women worldwide.
Researchers at Yale University found that progestin-therapy effectiveness depends on PR status in endometriotic lesions. Women with PR-positive lesions respond better to therapy, while those with PR-negative lesions find little relief. This study suggests a personalized approach to treating endometriosis may be more effective.
A study found that progesterone receptor levels can predict response to progestin-based therapy in endometriosis. This discovery may lead to faster and more effective treatment options for women with the condition.
A large prospective study has found that childhood sexual and physical abuse is associated with a greater risk of endometriosis diagnosed during adulthood. Women reporting severe-chronic abuse had a 79 percent increased risk of laparoscopically-confirmed endometriosis.
Fatigue is a common symptom of endometriosis, affecting over half of diagnosed women, with links also found to childhood abuse and neglect. The study suggests that endometriosis may cause fatigue independently of other factors, possibly due to inflammation and immune system activation.
Researchers studied thiostrepton's effects on endometriosis using an endometriotic rat model. Thiostrepton, a FOXM1 inhibitor, reduced expression of key proteins in endometriotic lesions. This suggests thiostrepton may inhibit endometriosis growth by decreasing FOXM1 expression and exerting a pro-apoptotic effect.
Researchers developed a novel non-invasive diagnostic method for endometriosis based on menstrual blood, reducing the need for invasive abdominal surgery and improving early diagnosis. The study found that stem cells in menstrual blood of women with endometriosis were different from those of healthy women.
Researchers at Oak Ridge National Laboratory have made significant advancements in identifying microbes linked to endometriosis, a condition that causes painful lesions and infertility. The lab has also developed a low-power neuromorphic device capable of quickly analyzing complex data sets, promising applications in scientific research.
A new meta-analysis reveals that pregnant women with endometriosis are at higher risk for complications such as preterm birth, miscarriage, and small-for-gestational-age infants. The study also shows no association between endometriosis and gestational hypertension or preeclampsia.
Women who breastfed for longer periods had significantly lower risk of being diagnosed with endometriosis, with exclusive breastfeeding offering even greater protection. Longer durations of breastfeeding were associated with an 8-14% drop in risk, and women who breastfed exclusively across multiple pregnancies saw a nearly 30% lower risk.
Endometriosis affects an estimated 176 million women worldwide, causing chronic pain, heavy bleeding, and infertility. The project identified key priorities, including better diagnosis tools, emotional support, and fertility preservation methods.
A recent gene sequencing study has identified unusual genetic mutations in women with benign endometriosis, a painful disorder marked by uterine tissue growth outside the womb. The findings may eventually help scientists develop molecular tests to distinguish between aggressive and clinically indolent types of endometriosis.
A study published in Scientific Reports found that endometriosis severely compromises egg quality by blocking maturation and causing damage from reactive oxygen species. Antioxidants may help prevent this damage, providing a potential solution for women struggling with infertility.
A study on mice suggests that endometriosis has a distinct lipid profile that could lead to a less invasive diagnostic test. The researchers found a difference in lipid metabolism between mice with the disorder and control animals.
A new study from Brigham and Women's Hospital suggests that the majority of women with endometriosis do not experience infertility, contradicting previous estimates. The study found a higher risk of subsequent infertility in women under age 35, but only half of cases previously thought to be related to endometriosis.
A new study found that endocrine-disrupting chemicals may contribute to reproductive health problems, including uterine fibroids and endometriosis, affecting millions of women worldwide. The estimated cost of these conditions in the European Union is €1.4 billion annually.
Researchers found that nearly 30% of reproductive-age women experienced chronic or cyclic pelvic pain, with endometriosis women reporting higher levels of pain. Physicians may want to ask patients about pain during routine visits, and women should inform their doctors about any pain they're experiencing.
A nationwide analysis of 14,655 women found that those with endometriosis have a higher risk of early pregnancy loss and later complications. Women with a history of endometriosis are also at a higher risk of haemorrhage, preterm birth, and other issues.
A new University of Adelaide study discovered an association between contact with seminal fluid and the development of endometriosis. The research found that seminal fluid enhances the survival and growth of endometriosis lesions, potentially increasing the risk of progression in women.
Researchers have discovered two new drug compounds that target endometriosis by interacting with estrogen receptors, reducing inflammation and tissue growth. The compounds, OBHS and CLI, showed promising results in mouse models and human cell cultures, offering a potential new approach to treating the disorder.
Researchers at UCSF have identified patterns of genetic activity that can be used to diagnose endometriosis and its severity, offering a less invasive alternative to surgery. The test uses machine learning to analyze gene expression patterns in uterine lining cells.
A Monash University study found that endometriosis often takes a long time to be diagnosed and impacts various areas of a woman's life. Common symptoms include painful menstruation, heavy menstrual bleeding, and infertility.
A mouse model of endometriosis has been developed that produces lesions similar to those found in humans. The study suggests that macrophages present in shed endometrium contribute to the development of endometriotic lesions, providing new insights into the disease.
Researchers uncover complement pathway as primary immune mechanism driving endometriosis and ovarian cancer development. The discovery may lead to targeted preventive measures, such as immune therapy, for women with endometriosis at increased cancer risk.
A new theory proposes that epigenetic modification plays a key role in the development of endometriosis, a chronic disease affecting 1 in 10 women. The research suggests that alterations in the epigenetic landscape, rather than genetic mutations, contribute to the disease's progression.
Researchers have identified a distinctive profile of cytokine activity associated with certain symptoms of endometriosis, including ovarian and rectovaginal lesions. This signature is negatively correlated with patient fertility and has previously been implicated in the disease.
A Fred Hutchinson Cancer Center-led study has found a link between two organochlorine pesticides and an increased risk of endometriosis. Women with higher exposures to these pesticides had a 30- to 70-percent increase in endometriosis risk, according to the study.
A recent study found that morbidly obese women have a significantly lower risk of developing endometriosis compared to those with low normal BMI. The association was strongest in infertile women, who had a 77% lower rate of endometriosis
A research team led by Nalini Santanam is investigating the epigenetics of pain in endometriosis, with preliminary findings suggesting that epigenetic markers may play a role in the disease's development. The team hopes to find new biomarkers for diagnostics and personalized treatment approaches.
A novel study suggests that surgical removal of an ovary and visible endometriosis significantly lower ovarian cancer risk in women with endometriosis. Hormonal treatments, however, did not show a protective effect against ovarian cancer.
Researchers have discovered a potent physiological anti-angiogenic factor, PEDF, that reverses symptoms of endometriosis and ovarian hyperstimulation syndrome without compromising fertility. The injectable protein has shown promising results in pre-clinical studies.
A possible link between benzophenone sunscreens and endometriosis has been identified by researchers. High levels of 2,4OH-BP were associated with an increased risk of endometriosis diagnosis in a study of 625 women.
Women with a history of endometriosis are at a significantly higher risk of developing three specific types of ovarian cancer. The study found that endometriosis is linked to a more than threefold chance of developing clear-cell ovarian cancers and over double the risk of developing endometrioid tumours.
Researchers at Yale University have discovered a new gene mutation that provides hope for new screening methods to identify women at risk of developing endometriosis. The study found that 31% of women with endometriosis carried the mutation, compared to 5.8% of the general population.
A nationwide Danish cohort study suggests women with endometriosis are 50% more likely to develop inflammatory bowel disease, a condition that affects the bowel and causes abdominal pain. The risk persists for over 20 years after diagnosis and is linked to common causes or treatment effects.
Research identifies two genetic variants associated with an increased risk of developing endometriosis, a condition characterized by pelvic pain and infertility. The variants were found on chromosomes 7 and 1, respectively, and are linked to hormone metabolism and the development of the female reproductive tract.
The study found substantial differences between women with endometriosis and controls, with lost work productivity averaging ten hours per week. Quality of life was also significantly impaired, except for physical functioning and mental health.